NCT05331833View on ClinicalTrials.gov

Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer.

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Stage III Non-small-cell Lung Cancer
Interventions
RADIATION

The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.

All Listed Sponsors
lead

Jianguo Sun

OTHER

NCT05331833 - Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer. | Biotech Hunter | Biotech Hunter